课题基金 / 基金详情

The pathophysiological significanse and mechanism of activation of key enzyme responsible for adenosine production in ischemic preconditioning.

The pathophysiological significanse and mechanism of activation of key enzyme responsible for adenosine production in ischemic preconditioning.
缺血预处理中负责腺苷产生的关键酶的病理生理意义和激活机制。
批准号:
07457171
负责人:
HORI Masatsugu
金额:
$4.8万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

HORI Masatsugu的其他基金

相似基金

相关文献

中文摘要
翻译
我们已经报道,在化学预适应(IP)中,心脏保护归因于激活ECTO-5‘-核苷酸酶(ECTO-5’NT),ECTO-5‘NT是犬心肌产生腺苷的关键酶,而ECTO-5’NT是由蛋白激酶C(PKC)激活的。开胸犬冠脉结扎4次,每次5分钟,间隔5分钟。心肌细胞胞外5‘NT活性和腺苷释放增加,但两者均被胞外5’NT抑制剂(AMP-CP)钝化。此外,短暂给予甲氧胺(α1-肾上腺素受体激动剂)和PMA(蛋白激酶C激活剂)(甲氧胺,α1-肾上腺素能受体激动剂)和PMA(蛋白激酶C激活剂),可模拟缺血预适应(IP)后ECTO-5‘NT活性的增加和心肌梗死面积的限制作用。其次,我们验证了缺血预适应(IP)是由于α-PKC激活而导致缺血预适应(IP)激活…膜上2+和gt;依赖的PKC的假设更多派系。免疫印迹法(IB)显示,与对照组相比,心肌组织中α-PKC的含量增加,而β-、β-和epsilon-PKC的含量没有变化。在相同的膜组分中,外向-5‘-NT活性增加。然后,我们检测了在犬的预适应心肌中,PKC是否磷酸化了ecto-5‘T。免疫沉淀的ecto-5‘NT是带有抗磷酸化抗体的IB。我们观察了免疫沉淀物ecto-5‘NT的丝氨酸-茶氨酸磷酸化。此外,蛋白激酶C特异性抑制剂GY109203X可钝化IP引起的PKC和ECTO-5‘NT活性的升高,并且不能检测到免疫沉淀的ECTO-5’NT的丝氨酸-苏氨酸磷酸化。我们的结论是,心肌中的ECTO-5‘NT被IP中的PKC磷酸化并激活,从而增加了腺苷释放酶。通过磷酸化激活ECTO-5‘NT是IP心脏保护的重要机制。较少
英文摘要
We have reported that cardioprotection in is chemic preconditining (IP) is attributable to activation of ecto-5'-nucleotidase (ecto-5'NT), akey enzyme responsible for adenosine production in the canine myocadium, and that ecto-5'NT is activated by protein kinase C (PKC). In the open chest dogs, IP was produced by 4 times of 5-min coronary occlusion with a 5-min interval. Myocardial ecto-5'NT activity and adenosine release were increased after IP,but both were blunted by an inhibitor of ecto-5'NT (AMP-CP). The infarct size-limiting effect was also blunted by AMP-CP.Futhermore, transient administration (4 times of 5-min coronary infusion with a 5-min interval) of methoxamine (an stimulator of alpha 1-adrenoceptor) and PMA (an activator of PKC) mimicked the increase in ecto-5'NT activity and the infarct size-limiting effect after IP.Next, we tested the hypothesis that ischemic preconditining (IP) is attributable to activation of alpha-PKC.IP activated Ca^<2+>-dependent PKC of the membrane … More faction. Immunoblotting (IB) of the membrane fraction revealed the increases in the contents of alpha-PKC without changing the contents of beta-, delta-, and epsilon-PKC compared with the control myocardium. In the same membrane fractions, ecto-5'NT activity increased. And then, we examined whether PKC phospholylates ecto-5' T in the canine preconditioned myocardium. Immunoprecipitated ecto-5'NT was IB with antiphosphorylation antibodies. We observed the serine-theonine phosphorylation of immunoprecipitated ecto-5'NT due to the IP procedure. Futhermore, the increases in the activities of PKC and ecto-5'NT due to IP were blunted and the serine-threonine phosphorylation of immunoprecipitated ecto-5'NT was not detected by GY109203X (a specific inhibitor of protein kinase C). We conclude that ecto-5'NT in the myocardium is phosphorylated and activated by PKC in the IP to increase the adenosine relase. Activation of ecto-5'NT by phosphorylation is an important mechanism for cadioprotection in IP. Less
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
堀 正二: "Ischemic Preconditioningにおけるアデノシンの役割" 診断と新薬. 33(7). 1125-1127 (1996)
Shoji Hori:“腺苷在缺血预处理中的作用”诊断和新药 33(7) (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
堀 正二: "Ishemic Preconditioning" 77(6). 1215- (1996)
Shoji Hori:“缺血预处理”77(6)1215-(1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
堀 正二: "目でみる冠動脈疾患の病態生理" メディカルレビュー社, 5-10 (1996)
Shoji Hori:“冠状动脉疾病的视觉病理生理学”医学评论出版,5-10(1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Cardiac stress-responsive mechanism and its theraprutic application
    • 批准号:
      11307013
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $5.76万
    • 财政年份:
      1999
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    Molecular epidemiology of acute coronary syndrome in Japan : Large-scale, prospective, multicenter clinical investigation
    • 批准号:
      11794035
    • 项目类别:
      Grant-in-Aid for University and Society Collaboration
    • 资助金额:
      $11.71万
    • 财政年份:
      1999
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    Prevention of atherosclerotic plaque rupture by the regulation of oxygen radical metabolism of vascular wall cells.
    • 批准号:
      10557071
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.64万
    • 财政年份:
      1998
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    Development of in vitro reconstituted system for investigating intracellular signal trasduction and cellular function in myocardial cells
    • 批准号:
      07557057
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $9.6万
    • 财政年份:
      1995
    • 负责人:
      HORI Masatsugu
    • 依托单位:
    海外基金